Literature DB >> 16583687

Considerations on the possibilities and limitations of comprehensive normal phase-reversed phase liquid chromatography (NPLC x RPLC).

Isabelle François1, André de Villiers, Pat Sandra.   

Abstract

A comprehensive normal phase system LC-reversed phase LC (NPLC x RPLC) was evaluated for the separation of a pharmaceutical mixture and citrus oil extracts. NPLC was performed on a 25 cm x 1 mm ID x 5 microm dp diol phase. In the second dimension, an RP 18 monolithic column (10 cm L x 4.6 mm ID x 2 microm macropore size) and an octadecyl silicagel-packed column (5 cm L x 4.6 mm ID x 3.5 microm dp) were applied for the analyses of the pharmaceutical sample and the citrus oil extracts, respectively. A two-position/ten-port switching valve was used as interface. Under optimised LC conditions, the high degree of orthogonality between NP and RP resulted in peak capacities of 300 for the pharmaceutical sample and of 450 for the citrus oil extract composed of lemon and orange oil. Despite the features of NPLC x RPLC, several shortcomings related with the solvent incompatibility between the two LC modes were identified and the practical consequences were discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583687     DOI: 10.1002/jssc.200500451

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  2 in total

1.  Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization.

Authors:  Maggie P Y Lam; S O Siu; Edward Lau; Xiuli Mao; H Z Sun; Philip C N Chiu; William S B Yeung; David M Cox; Ivan K Chu
Journal:  Anal Bioanal Chem       Date:  2010-07-15       Impact factor: 4.142

2.  Reducing Dilution and Analysis Time in Online Comprehensive Two-Dimensional Liquid Chromatography by Active Modulation.

Authors:  Andrea F G Gargano; Mike Duffin; Pablo Navarro; Peter J Schoenmakers
Journal:  Anal Chem       Date:  2016-01-08       Impact factor: 6.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.